This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Imitrex (2013-11-01)

Starting date:
November 1, 2013
Posting date:
November 21, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-36691

Recalled products

Imitrex 

Reason

The above two batches of Imitrex pre-filled syringes were packaged with needles that may have protruded through the needle shield.

Depth of distribution

Wholesalers, hospitals, pharmacies across Canada

Affected products

Imitrex

DIN, NPN, DIN-HIM
DIN 02212188
Dosage form

Injection

Strength
  • 12 mg/mL
Lot or serial number
  • C632842
  • C637078
Companies
Recalling Firm
GlaxoSmithKline Inc.
7333 Mississauga Road North
Mississauga
L5N 6L4
Ontario
CANADA
Marketing Authorization Holder
GlaxoSmithKline Inc.
7333 Mississauga Road North
Mississauga
L5N 6L4
Ontario
CANADA

Date modified: